HBB rs121908736: Understanding This Rare Genetic Variant
The rs121908736 variant is a rare genetic change located within the HBB gene, which provides instructions for making hemoglobin. This variant has been studied for its potential role in beta-thalassemia, a condition that affects the production of healthy red blood cells.
What each genotype means
Typical hemoglobin production
This genotype represents the common, non-variant form of the HBB gene at this position. Individuals with this genotype do not carry the specific mutation associated with this variant's risk for beta-thalassemia.
This is the most common genotype found in the general population across all ancestries.
Beta-thalassemia carrier status
Carrying one copy of this variant means you are a carrier for a form of beta-thalassemia. While carriers are typically asymptomatic, you should discuss this result with a genetic counselor or clinician to understand implications for family planning and potential inheritance patterns.
This genotype is rare in the general population, with specific frequencies varying significantly by ancestry.
Increased beta-thalassemia risk
This genotype indicates the presence of two copies of the variant, which is associated with the development of beta-thalassemia. Because this condition is inherited in an autosomal recessive manner, individuals with this genotype may experience symptoms related to impaired hemoglobin production and should consult with a hematologist or medical professional for clinical evaluation.
This genotype is very rare in the general population.
What is rs121908736?
The rs121908736 variant is a specific change in the DNA sequence of the HBB gene, which is located on chromosome 11. In the context of genetic research, an rsID (reference SNP identification number) like rs121908736 acts as a unique label for a specific location in the human genome where a single nucleotide—the building block of DNA—may differ between individuals. This particular variant is categorized as a trait-associated variant, meaning researchers have investigated its presence in relation to specific health conditions. Because it is located within the HBB gene, it is of interest to scientists studying how variations in our genetic code can influence the structure and function of proteins essential for life, such as hemoglobin.
The Role of the HBB Gene
The HBB gene is responsible for providing the instructions to create a protein called beta-globin. Beta-globin is a vital component of hemoglobin, the protein inside red blood cells that carries oxygen from the lungs to the rest of the body. When the HBB gene functions normally, it ensures that the body produces enough beta-globin to form healthy, stable hemoglobin. However, because the HBB gene is complex, even small changes in its sequence can disrupt the production or structure of beta-globin. When these instructions are altered, it can lead to a reduction in hemoglobin levels, which is the underlying mechanism for a group of blood disorders known as hemoglobinopathies, including beta-thalassemia.
Research and Evidence
Current research into rs121908736 focuses on its association with beta-thalassemia. Beta-thalassemia is a condition characterized by reduced or absent production of beta-globin, leading to anemia and other health challenges. Evidence for this specific variant is considered moderate, as clinical studies continue to evaluate how it impacts the splicing of mRNA—the process by which genetic instructions are prepared for protein synthesis. While loss-of-function mutations in the HBB gene are well-established as a cause of beta-thalassemia, the clinical significance of any single variant can depend on whether it is inherited from one or both parents. Because this is a rare variant, ongoing research is essential to fully understand its specific impact on hemoglobin production and individual health outcomes.
Population Frequency
The rs121908736 variant is classified as rare in the general population. Genetic databases indicate that it does not appear at high frequencies across major ancestral groups. Because it is rare, most individuals will not carry this variant. Its low frequency means that large-scale population studies are required to gather enough data to draw definitive conclusions about its prevalence and its specific contribution to health traits in different ethnic or geographic populations.
What This Information Means for You
Learning about a genetic variant like rs121908736 can be an educational experience, but it is important to remember that genetic information is only one piece of a much larger health puzzle. This information is not a medical diagnosis and cannot predict your specific health future. If you have concerns about your hemoglobin levels, blood health, or family history of anemia, the most important step is to consult with a healthcare professional or a genetic counselor. They can interpret your results in the context of your overall health, medical history, and physical symptoms. Never make changes to your health management or medication based on genetic data without first discussing it with your clinician or pharmacist.
How common is this variant?
The rs121908736 variant is rare, appearing at very low frequencies in global population databases.
Frequently asked questions
What is beta-thalassemia?
Beta-thalassemia is an inherited blood disorder characterized by reduced or absent production of beta-globin, a component of hemoglobin. This reduction can lead to anemia and may require medical management.
Does having this variant mean I have a disease?
No, identifying a genetic variant does not constitute a medical diagnosis. Many factors, including other genes and environmental influences, determine health outcomes.
Should I get tested for this variant?
Genetic testing is typically recommended by healthcare providers based on family history or clinical symptoms. You should discuss the necessity of testing with your doctor.
Where can I find more information about HBB variants?
Resources like MedlinePlus Genetics and the National Center for Biotechnology Information (NCBI) provide reliable, evidence-based information on the HBB gene and related conditions.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908736?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HBB
This variant is a pathogenic mutation in the HBB gene associated with beta-thalassemia.
This variant is a pathogenic mutation in the HBB gene associated with hemoglobinopathies such as sickle cell disease.
This variant (c.20A>T, p.Glu7Val) causes the substitution of valine for glutamic acid in the beta-globin chain, leading to sickle cell trait or disease depending on zygosity.
Pathogenic variant (p.Glu6Val, HbS-Antilles) in HBB associated with sickle cell disease-like pathology.
Pathogenic nonsense mutation (c.118C>T / p.Gln40Ter / codon 39 nonsense) causing beta-zero thalassemia and classic carrier status (beta-thalassemia minor).
This variant, known as Hb C-Harlem, involves a double mutation in the HBB gene that can lead to sickle-beta-thalassemia-like phenotypes.